Literature DB >> 8460134

Identification of Ras farnesyltransferase inhibitors by microbial screening.

M Hara1, K Akasaka, S Akinaga, M Okabe, H Nakano, R Gomez, D Wood, M Uh, F Tamanoi.   

Abstract

A microbial screen using a yeast strain with conditional deficiency in the GPA1 gene was carried out to search for inhibitors of protein farnesyltransferase (PFT). A strain of Streptomyces was found to produce active compounds named UCF1-A, UCF1-B, and UCF1-C. Structural determination of these compounds revealed that UCF1-C is identical to the known antibiotic, manumycin, whereas UCF1-A and UCF1-B are structurally related to manumycin. All three UCF1 compounds suppress the lethality of gpa1 disruption, with UCF1-C exhibiting the strongest activity. UCF1 inhibits yeast as well as rat brain PFT. Fifty percent inhibition of yeast PFT activity is observed with 5 microM UCF1-C. Kinetic analyses of the inhibition suggest that UCF1-C acts as a competitive inhibitor of PFT with respect to farnesyl pyrophosphate, exhibiting a Ki of 1.2 microM, whereas the same compound appears to act as a noncompetitive inhibitor of PFT with respect to the farnesyl acceptor, the Ras protein. UCF1-C shows significant activity to inhibit the growth of Ki-ras-transformed fibrosarcoma, raising the possibility of its use as an antitumor drug.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460134      PMCID: PMC46070          DOI: 10.1073/pnas.90.6.2281

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  [METABOLITES OF MICROORGANISMS. 41. MANUMYCIN].

Authors:  F BUZZETTI; E GAEUMANN; R HUETTER; W KELLER-SCHIERLEIN; L NEIPP; V PRELOG; H ZAEHNER
Journal:  Pharm Acta Helv       Date:  1963-12

2.  Common modifications of trimeric G proteins and ras protein: involvement of polyisoprenylation.

Authors:  A A Finegold; W R Schafer; J Rine; M Whiteway; F Tamanoi
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

3.  Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides.

Authors:  Y Reiss; J L Goldstein; M C Seabra; P J Casey; M S Brown
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

4.  Xenopus oocyte germinal-vesicle breakdown induced by [Val12]Ras is inhibited by a cytosol-localized Ras mutant.

Authors:  J B Gibbs; M D Schaber; T L Schofield; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  The structure of manumycin. II. Derivatives.

Authors:  A Zeeck; K Frobel; C Heusel; K Schröder; R Thiericke
Journal:  J Antibiot (Tokyo)       Date:  1987-11       Impact factor: 2.649

6.  GPA1, a haploid-specific essential gene, encodes a yeast homolog of mammalian G protein which may be involved in mating factor signal transduction.

Authors:  I Miyajima; M Nakafuku; N Nakayama; C Brenner; A Miyajima; K Kaibuchi; K Arai; Y Kaziro; K Matsumoto
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

7.  Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans.

Authors:  W R Schafer; R Kim; R Sterne; J Thorner; S H Kim; J Rine
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

8.  A new antibiotic,, asukamycin, produced by Streptomyces.

Authors:  S Omura; C Kitao; H Tanaka; R Oiwa; Y Takahashi
Journal:  J Antibiot (Tokyo)       Date:  1976-09       Impact factor: 2.649

9.  The structure of manumycin. I. Characterization, structure elucidation and biological activity.

Authors:  A Zeeck; K Schröder; K Frobel; R Grote; R Thiericke
Journal:  J Antibiot (Tokyo)       Date:  1987-11       Impact factor: 2.649

10.  Mutants of H-ras that interfere with RAS effector function in Saccharomyces cerevisiae.

Authors:  T Michaeli; J Field; R Ballester; K O'Neill; M Wigler
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

View more
  49 in total

1.  Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis.

Authors:  Jindrich Cinatl; Martin Michaelis; Pablo Hernáiz Driever; Jaroslav Cinatl; Jan Hrabeta; Tatyana Suhan; Hans Wilhelm Doerr; Jens-Uwe Vogel
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

2.  Structures of Cryptococcus neoformans protein farnesyltransferase reveal strategies for developing inhibitors that target fungal pathogens.

Authors:  Michael A Hast; Connie B Nichols; Stephanie M Armstrong; Shannon M Kelly; Homme W Hellinga; J Andrew Alspaugh; Lorena S Beese
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

3.  Protein farnesyltransferase in plants: molecular characterization and involvement in cell cycle control.

Authors:  D Qian; D Zhou; R Ju; C L Cramer; Z Yang
Journal:  Plant Cell       Date:  1996-12       Impact factor: 11.277

4.  Rational design of small molecule inhibitors targeting the Ras GEF, SOS1.

Authors:  Chris R Evelyn; Xin Duan; Jacek Biesiada; William L Seibel; Jaroslaw Meller; Yi Zheng
Journal:  Chem Biol       Date:  2014-11-20

5.  Combined rational design and a high throughput screening platform for identifying chemical inhibitors of a Ras-activating enzyme.

Authors:  Chris R Evelyn; Jacek Biesiada; Xin Duan; Hong Tang; Xun Shang; Ruben Papoian; William L Seibel; Sandra Nelson; Jaroslaw Meller; Yi Zheng
Journal:  J Biol Chem       Date:  2015-03-30       Impact factor: 5.157

Review 6.  Biology, pathology, and therapeutic targeting of RAS.

Authors:  J Matthew Rhett; Imran Khan; John P O'Bryan
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

7.  Actinoplanic acids A and B as novel inhibitors of farnesyl-protein transferase.

Authors:  K C Silverman; C Cascales; O Genilloud; J M Sigmund; S E Gartner; G E Koch; M M Gagliardi; B K Heimbuch; M Nallin-Omstead; M Sanchez
Journal:  Appl Microbiol Biotechnol       Date:  1995 Aug-Sep       Impact factor: 4.813

8.  Consequences of altered isoprenylation targets on a-factor export and bioactivity.

Authors:  G A Caldwell; S H Wang; F Naider; J M Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

Review 9.  Antitumor compounds from marine actinomycetes.

Authors:  Carlos Olano; Carmen Méndez; José A Salas
Journal:  Mar Drugs       Date:  2009-06-11       Impact factor: 5.118

10.  A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.

Authors:  Zhi Sheng; Li Li; Lihua J Zhu; Thomas W Smith; Andrea Demers; Alonzo H Ross; Richard P Moser; Michael R Green
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.